InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[DDobserver]

Besides a broad negative view and concern with the current administrations ability to keep promises and pass positive legislation there are a few other items at play. Check the SEC filings insider trading is abyssmal.

Then you have Brexit. Goldman Sachs is concerned enough that they are pulling out a least a thousand employees from Great Britain. Many other companies are doing the same thing due to uncertainty.

Here in Europe there is a strong flow of money coming in from Brexit. Albeit that other countries are lobbying to get out of the EU as well. Major uncertainty especially since medical device and bio is a long term venture with plenty of lows full of pitfalls which includes NVIV and the absoluteness that this will not be viable for another eighteen months minimum no matter how many censors want to believe otherwise.